Bioelectronics coming to a hospital near you
Apple is using biomedical engineers, close to its HQ in Palo Alto, in an initiative to develop sensors to treat diabetes. The line between pharmaceuticals and technology is blurring as companies are joining forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware, in the field of medicine called bioelectronics.
Last year, GlaxoSmithKline and Google parent Alphabet unveiled a joint company aimed at marketing bio-electronic devices to fight illness by attaching to individual nerves. Other companies investing in bioelectronics include Medtronic, Proteus Digital Technology, Sanofi SA, Setpoint Medical, EnteroMedics and Biogen.